| |  Online-Ressource |
|---|
| Verfasst von: | Werner, Julia [VerfasserIn]  |
|---|
| | Umstätter, Florian [VerfasserIn] |
|---|
| | Hertlein, Tobias [VerfasserIn] |
|---|
| | Beijer, Barbro [VerfasserIn] |
|---|
| | Kleist, Christian [VerfasserIn] |
|---|
| | Mühlberg, Eric [VerfasserIn] |
|---|
| | Zimmermann, Stefan [VerfasserIn] |
|---|
| | Haberkorn, Uwe [VerfasserIn] |
|---|
| | Ohlsen, Knut [VerfasserIn] |
|---|
| | Fricker, Gert [VerfasserIn] |
|---|
| | Mier, Walter [VerfasserIn] |
|---|
| | Uhl, Philipp [VerfasserIn] |
|---|
| Titel: | Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier |
|---|
| Verf.angabe: | Julia Werner, MSc, Florian Umstätter, PhD, Tobias Hertlein, PhD, Barbro Beijer, PhD, Christian Kleist, PhD, Eric Mühlberg, MSc, Stefan Zimmermann, MD, Uwe Haberkorn, MD, Knut Ohlsen, PhD, Gert Fricker, PhD, Walter Mier, PhD, Philipp Uhl, PhD |
|---|
| E-Jahr: | 2024 |
|---|
| Jahr: | February 2024 |
|---|
| Umfang: | 8 S. |
|---|
| Illustrationen: | Illustrationen |
|---|
| Fussnoten: | Online verfügbar: 27. Dezember 2023, Artikelversion: 3. Januar 2024 ; Gesehen am 12.06.2024 |
|---|
| Titel Quelle: | Enthalten in: Nanomedicine. Nanotechnology, biology and medicine |
|---|
| Ort Quelle: | New York, NY : Elsevier, 2005 |
|---|
| Jahr Quelle: | 2024 |
|---|
| Band/Heft Quelle: | 56(2024) vom: Feb., Artikel-ID 102731, Seite 1-8 |
|---|
| ISSN Quelle: | 1549-9642 |
|---|
| Abstract: | Antibiotic resistance still represents a global health concern which diminishes the pool of effective antibiotics. With the vancomycin derivative FU002, we recently reported a highly potent substance active against Gram-positive bacteria with the potential to overcome vancomycin resistance. However, the translation of its excellent antimicrobial activity into clinical efficiency could be hampered by its rapid elimination from the blood stream. To improve its pharmacokinetics, we encapsulated FU002 in PEGylated liposomes. For PEG-liposomal FU002, no relevant cytotoxicity on liver, kidney and red blood cells was observed. Studies in Wistar rats revealed a significantly prolonged blood circulation of the liposomal antibiotic. In microdilution assays it could be demonstrated that encapsulation does not diminish the antimicrobial activity against staphylococci and enterococci. Highlighting its great potency, liposomal FU002 exhibited a superior therapeutic efficacy when compared to the free form in a Galleria mellonella larvae infection model. |
|---|
| DOI: | doi:10.1016/j.nano.2023.102731 |
|---|
| URL: | Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.
kostenfrei: Volltext: https://doi.org/10.1016/j.nano.2023.102731 |
|---|
| | kostenfrei: Volltext: https://www.sciencedirect.com/science/article/pii/S1549963423000825 |
|---|
| | DOI: https://doi.org/10.1016/j.nano.2023.102731 |
|---|
| Datenträger: | Online-Ressource |
|---|
| Sprache: | eng |
|---|
| Sach-SW: | Antibiotic resistance |
|---|
| | Liposomes |
|---|
| | Polyethylene glycol |
|---|
| | Vancomycin derivative FU002 |
|---|
| | Vancomycin-resistant enterococci |
|---|
| K10plus-PPN: | 1891111833 |
|---|
| Verknüpfungen: | → Zeitschrift |
|---|
Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier / Werner, Julia [VerfasserIn]; February 2024 (Online-Ressource)
